https://annual-report.bms.com/assets/bms-ar/documents/2023/2023-bms-financial-report.pdf https://www.astrazeneca.com/content/dam/az/PDF/2022/fy/Full-year-and-Q4-2022-results-announcement.pdf https://www.astrazeneca.com/content/dam/az/PDF/2023/fy/Full-year-and-Q4-2023-results-announcement...
UPM Annual Report 2024, Corporate Governance Statement and Remuneration Report published Essity Included in S&P Global Sustainability Yearbook 2025 and Dow Jones Sustainability Index AF&PA Responds to 25% Tariffs on Canada and Mexico Sonoco Showcases its Award-Winning Paper Can ...
We limit data available in the Overview Report for users who do not have Powerpack Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data. Register an account and get your Powerpack now or Login ...
Annual profits - Rate of surprise My WatchlistMost popular (10)My previous session (0) NVIDIA CORPORATION +2.63% UNICREDIT S.P.A. +1.57% COMMERZBANK AG +1.35% APPLE INC. +1.27% AMD (ADVANCED MICRO DEVICES) +1.15% META PLATFORMS, INC. ...
been named a Product Challenger in Intelligent Document Processing (IDP) by the leading global technology research and advisory firm Information Services Group (ISG) in its Provider Lens(TM) Intelligent Automation Solutions and Services 2022 UK report and a high-ranking Contender in its US report. ...
Chart represents JBTM Revenue and Revenue Estimate over Annual period The chart has 1 X axis displaying time periods. The chart has 1 Y axis displaying values. Data ranges from 0 to 3685400000.. 0800M1.6B2.4B3.2B4B Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024 (E)Dec 2025 (E)...
Chart represents JBTM Revenue and Revenue Estimate over Annual period The chart has 1 X axis displaying time periods. The chart has 1 Y axis displaying values. Data ranges from 0 to 3685400000.. 0800M1.6B2.4B3.2B4B Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024 (E)Dec 2025 (E) En...
Verastem Oncology Announces Multiple Data Presentations At Society Of Gynecologic Oncology 2025 Annual Meeting On Women's CancerFeb. 20RE B. Riley Adjusts Verastem's Price Target to $9 From $7, Maintains Buy RatingJan. 31MT Verastem Names Matthew E. Ros as COOJan. 15MT ...
6.830USD-5.53% -3.78%+33.08% Feb. 20Verastem Oncology Announces Multiple Data Presentations At Society Of Gynecologic Oncology 2025 Annual Meeting On Women's CancerRE Jan. 31B. Riley Adjusts Verastem's Price Target to $9 From $7, Maintains Buy RatingMT ...
quotes Price Overview Performance Report charts Interactive Chart Snapshot Chart technicals Barchart Opinion Trading Strategies Top Trade Alerts Technical Analysis Trader's Cheat Sheet Seasonal Returns Price History Historical Data options Options Prices Volatility & Greeks Options Flow Options Time & Sales...